Literature DB >> 22972556

Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients.

Marco Guarneri1, Calogero Geraci, Francesca Incalcaterra, Rosalia Arsena, Giuseppe Mulè, Francesco Vaccaro, Clelia Luna, Giovanni Cerasola, Santina Cottone.   

Abstract

The intima-media thickness (IMT) is considered as a surrogate marker for atherosclerotic disease. The aim of this study was to analyze the relationship of carotid IMT with fetuin-A in patients with essential hypertension (EH) and normal renal function. The plasma levels of fetuin-A, interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α) and the biomarker of oxidative stress 8-iso-PGF2alpha were assayed in samples from 105 untreated EH patients. Carotid IMT measurements were also performed. EH was studied overall and after dividing in EH with IMT ≥ and <0.9 mm. All of the biomarkers were significantly different between the two subgroups, in particular, the fetuin-A level was lower in the patients with an IMT ≥0.9 mm. In the overall group, the linear analysis of correlation demonstrated that the IMT was significantly inversely correlated with the fetuin-A level (r=-0.40, P<0.0001) and directly with TNF-α (r=0.39, P<0.0001), IL-6 (r=0.38, P<0.0001) and 8-iso-PGF2alpha (r=0.356, P<0.0003). The multiple regression analysis performed that assigned IMT as a dependent variable showed that fetuin-A (β=-0.268, P<0.0001) was independently correlated with the IMT. Receiver-operator curves demonstrated that fetuin-A levels have a predictive power of IMT>0.9 mm (AUC (area under the curve) 0.738, P<0.0001). Our results suggest that in EH, fetuin-A is associated with the IMT independently of oxidative stress and renal function, thus predicting increases in the IMT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972556     DOI: 10.1038/hr.2012.136

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

Review 1.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

2.  Level of Serum Fetuin-A Correlates with Heart Rate in Obstructive Sleep Apnea Patients without Metabolic and Cardiovascular Comorbidities.

Authors:  Elżbieta Reichert; Jerzy Mosiewicz; Wojciech Myśliński; Andrzej Jaroszyński; Agata Stanek; Klaudia Brożyna-Tkaczyk; Barbara Madejska-Mosiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-05-25       Impact factor: 4.614

3.  Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes.

Authors:  Hesham Alharby; Talaat Abdelati; Mostafa Rizk; Eman Youssef; Khaled Moghazy; Noha Gaber; Saeed Yafei
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-09-10

4.  Causal association pathways between fetuin-A and kidney function: a mediation analysis.

Authors:  Philip Etabee Bassey; Pawin Numthavaj; Sasivimol Rattanasiri; Piyamitr Sritara; Mark McEvoy; Boonsong Ongphiphadhanakul; Ammarin Thakkinstian
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

5.  Circulating calcification inhibitors are associated with arterial damage in pediatric patients with primary hypertension.

Authors:  Piotr Skrzypczyk; Anna Stelmaszczyk-Emmel; Michał Szyszka; Anna Ofiara; Małgorzata Pańczyk-Tomaszewska
Journal:  Pediatr Nephrol       Date:  2021-02-18       Impact factor: 3.714

6.  Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni; Stella Douma; Georgios Efstratiadis; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2013-06-12       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.